Canaccord Genuity Maintains Hold on Edwards Lifesciences, Lowers Price Target to $85

Canaccord Genuity analyst William Plovanic maintains Edwards Lifesciences (NYSE:EW) with a Hold and lowers the price target from $87 to $85.